Static Chart Thiogenesis Therapeutics, Corp. OTC Markets

Stocks

Market Closed - OTC Markets 09:54:44 2026-09-14 EDT			5-day change	1st Jan Change
0.3671 ^USD	-12.57%		-12.57%	-37.08%

08-06	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

Duration

Period